N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential

Abstract N7-methylguanosine (m7G) is an important RNA modification involved in epigenetic regulation that is commonly observed in both prokaryotic and eukaryotic organisms. Their influence on the synthesis and processing of messenger RNA, ribosomal RNA, and transfer RNA allows m7G modifications to a...

Full description

Saved in:
Bibliographic Details
Main Authors: Qihui Wu, Xiaodan Fu, Guoqian Liu, Xiaoyun He, Yimin Li, Chunlin Ou
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Hematology & Oncology
Subjects:
Online Access:https://doi.org/10.1186/s13045-025-01665-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571360731201536
author Qihui Wu
Xiaodan Fu
Guoqian Liu
Xiaoyun He
Yimin Li
Chunlin Ou
author_facet Qihui Wu
Xiaodan Fu
Guoqian Liu
Xiaoyun He
Yimin Li
Chunlin Ou
author_sort Qihui Wu
collection DOAJ
description Abstract N7-methylguanosine (m7G) is an important RNA modification involved in epigenetic regulation that is commonly observed in both prokaryotic and eukaryotic organisms. Their influence on the synthesis and processing of messenger RNA, ribosomal RNA, and transfer RNA allows m7G modifications to affect diverse cellular, physiological, and pathological processes. m7G modifications are pivotal in human diseases, particularly cancer progression. On one hand, m7G modification-associated modulate tumour progression and affect malignant biological characteristics, including sustained proliferation signalling, resistance to cell death, activation of invasion and metastasis, reprogramming of energy metabolism, genome instability, and immune evasion. This suggests that they may be novel therapeutic targets for cancer treatment. On the other hand, the aberrant expression of m7G modification-associated molecules is linked to clinicopathological characteristics, including tumour staging, lymph node metastasis, and unfavourable prognoses in patients with cancer, indicating their potential as tumour biomarkers. This review consolidates the discovery, identification, detection methodologies, and functional roles of m7G modification, analysing the mechanisms by which m7G modification-associated molecules contribute to tumour development, and exploring their potential clinical applications in cancer diagnostics and therapy, thereby providing innovative strategies for tumour identification and targeted treatment.
format Article
id doaj-art-22b40900d20942669383b6ea105b0c63
institution Kabale University
issn 1756-8722
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Hematology & Oncology
spelling doaj-art-22b40900d20942669383b6ea105b0c632025-02-02T12:37:55ZengBMCJournal of Hematology & Oncology1756-87222025-01-0118112210.1186/s13045-025-01665-7N7-methylguanosine modification in cancers: from mechanisms to therapeutic potentialQihui Wu0Xiaodan Fu1Guoqian Liu2Xiaoyun He3Yimin Li4Chunlin Ou5Department of Gynecology, Xiangya Hospital, Central South UniversityDepartment of Pathology, Xiangya Hospital, Central South UniversityDepartment of Pathology, Xiangya Hospital, Central South UniversityDepartments of Ultrasound Imaging, Xiangya Hospital, Central South UniversityDepartment of Pathology, Ruijin Hospital, Shanghai Jiaotong University School of MedicineDepartment of Gynecology, Xiangya Hospital, Central South UniversityAbstract N7-methylguanosine (m7G) is an important RNA modification involved in epigenetic regulation that is commonly observed in both prokaryotic and eukaryotic organisms. Their influence on the synthesis and processing of messenger RNA, ribosomal RNA, and transfer RNA allows m7G modifications to affect diverse cellular, physiological, and pathological processes. m7G modifications are pivotal in human diseases, particularly cancer progression. On one hand, m7G modification-associated modulate tumour progression and affect malignant biological characteristics, including sustained proliferation signalling, resistance to cell death, activation of invasion and metastasis, reprogramming of energy metabolism, genome instability, and immune evasion. This suggests that they may be novel therapeutic targets for cancer treatment. On the other hand, the aberrant expression of m7G modification-associated molecules is linked to clinicopathological characteristics, including tumour staging, lymph node metastasis, and unfavourable prognoses in patients with cancer, indicating their potential as tumour biomarkers. This review consolidates the discovery, identification, detection methodologies, and functional roles of m7G modification, analysing the mechanisms by which m7G modification-associated molecules contribute to tumour development, and exploring their potential clinical applications in cancer diagnostics and therapy, thereby providing innovative strategies for tumour identification and targeted treatment.https://doi.org/10.1186/s13045-025-01665-7N7-methylguanosineRNA modificationImmune evasionEnergy metabolismCell deathBiomarkers
spellingShingle Qihui Wu
Xiaodan Fu
Guoqian Liu
Xiaoyun He
Yimin Li
Chunlin Ou
N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential
Journal of Hematology & Oncology
N7-methylguanosine
RNA modification
Immune evasion
Energy metabolism
Cell death
Biomarkers
title N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential
title_full N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential
title_fullStr N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential
title_full_unstemmed N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential
title_short N7-methylguanosine modification in cancers: from mechanisms to therapeutic potential
title_sort n7 methylguanosine modification in cancers from mechanisms to therapeutic potential
topic N7-methylguanosine
RNA modification
Immune evasion
Energy metabolism
Cell death
Biomarkers
url https://doi.org/10.1186/s13045-025-01665-7
work_keys_str_mv AT qihuiwu n7methylguanosinemodificationincancersfrommechanismstotherapeuticpotential
AT xiaodanfu n7methylguanosinemodificationincancersfrommechanismstotherapeuticpotential
AT guoqianliu n7methylguanosinemodificationincancersfrommechanismstotherapeuticpotential
AT xiaoyunhe n7methylguanosinemodificationincancersfrommechanismstotherapeuticpotential
AT yiminli n7methylguanosinemodificationincancersfrommechanismstotherapeuticpotential
AT chunlinou n7methylguanosinemodificationincancersfrommechanismstotherapeuticpotential